BackAssembly Biosciences Overview

Assembly Biosciences Receivables

Track Assembly Biosciences's receivables ($820K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$822000.00

Peer trimmed avg / median

Loading

Assembly Biosciences Receivables History

Loading

Assembly Biosciences vs. peers: Receivables Comparison

Loading

Assembly Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Assembly Biosciences (ASMB) FAQ

Assembly Biosciences (ASMB) currently reports a receivables of $820K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Assembly Biosciences's receivables history and peer comparisons.

Assembly Biosciences's receivables changed from $0 to $820K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Assembly Biosciences reported $820K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $820K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Assembly Biosciences, and consider following ASMB for alerts when major investors trade the stock.

Assembly Biosciences is classified in the Healthcare sector. On receivables, it currently shows $820K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASMB with unrelated industries.